Ral activation promotes melanomagenesis

Oncogene

Volumn 29, Issue 34, 2010, Pages 4859-4864

  Zipfel, P A ^a,b   Brady, D C ^a   Kashatus, D F ^a   Ancrile, B D ^a   Tyler, D S ^a,b   Counter, C M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

melanoma; NRas; RalA; RalB

Indexed keywords

B RAF KINASE; GUANOSINE TRIPHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; RAL PROTEIN; RALA PROTEIN; RALB PROTEIN; RAS PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN; RALA PROTEIN, HUMAN; RALB PROTEIN, HUMAN;

ALLELE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MELANOMA; MELANOMAGENESIS; ONCOGENE N RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE; CELL GROWTH; GENETICS; METABOLISM; ONCOGENE RAS; PATHOLOGY;

ALLELES; CELL GROWTH PROCESSES; GENES, RAS; HUMANS; MELANOMA; PROTO-ONCOGENE PROTEINS B-RAF; RAL GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 77956171799     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.224     Document Type: Article

References (28)

1. 4859-4864Bodemann BO, White MA. (2008). Ral GTPases and cancer: linchpinsupport of the tumorigenic platform. Nat Rev Cancer 8,133-140.
2. Bodempudi V, Yamoutpoor F, Pan W, Dudek AZ, Esfandyari T,Piedra M et al. (2009). Ral overactivation in malignant peripheralnerve sheath tumors. Mol Cell Biol 29: 3964-3974.
3. Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL et al.(2006). RalB GTPase-mediated activation of the IkappaB familykinase TBK1 couples innate immune signaling to tumor cellsurvival. Cell 127: 157-170.
4. Chien Y, White MA. (2003). RAL GTPases are linchpin modulatorsof human tumour-cell proliferation and survival. EMBO R 4:800-806.
5. D'Adamo DR, Novick S, Kahn JM, Leonardi P, Pellicer A. (1997).rsc: a novel oncogene with structural and functional homologywith the gene family of exchange factors for Ral. Oncogene 14:1295-1305.
6. de Gorter DJ, Reijmers RM, Beuling EA, Naber HP, Kuil A,Kersten MJ et al. (2008). The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells. Blood 111:3364-3372.
7. Downward J. (2003). Targeting RAS signalling pathways in cancertherapy. Nat Rev Cancer 3: 11-22.
8. Falsetti SC, Wang DA, Peng H, Carrico D, Cox AD, Der CJ et al.(2007). Geranylgeranyltransferase I inhibitors target RalB toinhibit anchorage-dependent growth and induce apoptosis andRalA to inhibit anchorage-independent growth. Mol Cell Biol 27:8003-8014.
9. Feig LA. (2003). Ral-GTPases: approaching their 15 min of fame.Trends Cell Biol 13: 419-425.
10. Gonzalez-Garcia A, Pritchard CA, Paterson HF, Mavria G, Stamp G,Marshall CJ. (2005). RalGDS is required for tumor formation in amodel of skin carcinogenesis. Cancer Cell 7: 219-226.
11. Gray-Schopfer V, Wellbrock C, Marais R. (2007). Melanoma biologyand new targeted therapy. Nature 445: 851-857.
12. Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, AbrahamRT et al. (2002). Distinct requirements for Ras oncogenesis inhuman versus mouse cells. Genes Dev 16: 2045-2057.
13. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L et al. (1996). Oncogenic Ras activation ofRaf/mitogen-activated protein kinase-independent pathways issufficient to cause tumorigenic transformation. Mol Cell Biol 16:3923-3933.
14. Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox ADet al. (2005). Activation of RalA is critical for Ras-inducedtumorigenesis of human cells. Cancer Cell 7: 533-545.
15. Lim KH, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD et al.(2010). Aurora-A phosphorylates, activates, and relocalizes thesmall GTPase RalA. Mol Cell Biol 30: 508-523.
16. Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJet al. (2006). Divergent roles for RalA and RalB in malignant growthof human pancreatic carcinoma cells. Curr Biol 16: 2385-2394.
17. Miller MJ, Rioux L, Prendergast GV, Cannon S, White MA,Meinkoth JL. (1998). Differential effects of protein kinase A onRas effector pathways. Mol Cell Biol 18: 3718-3726.
18. Mishra PJ, Ha L, Rieker J, Sviderskaya EV, Bennett DC, Oberst MDet al. (2010). Dissection of RAS downstream pathways inmelanomagenesis: A role for Ral in transformation. Oncogene 29:2449-2456.
19. Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, SmithSC et al. (2005). RalA and RalB: antagonistic relatives in cancer cellmigration. Cancer Res 65: 7111-7120.
20. Rosse C, Hatzoglou A, Parrini MC, White MA, Chavrier P, CamonisJ. (2006). RalB mobilizes the exocyst to drive cell migration. MolCell Biol 26: 727-734.
21. Sablina AA, Chen W, Arroyo JD, Corral L, Hector M, Bulmer SEet al. (2007). The tumor suppressor PP2A Abeta regulates the RalAGTPase. Cell 129: 969-982.
22. Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, BrautiganDL et al. (2007). Expression of Ral GTPases, their effectors, andactivators in human bladder cancer. Clin Cancer Res 13: 3803-3813.
23. Sowalsky AG, Alt-Holland A, Shamis Y, Garlick JA, Feig LA. (2009).RalA suppresses early stages of Ras-induced squamous cellcarcinoma progression. Oncogene 29: 45-55.
24. Urano T, Emkey R, Feig LA. (1996). Ral-GTPases mediate a distinctdownstream signaling pathway from Ras that facilitates cellulartransformation. EMBO J 15: 810-816.
25. White MA, Vale T, Camonis JH, Schaefer E, Wigler MH. (1996). Arole for the Ral guanine nucleotide dissociation stimulatorin mediating Ras-induced transformation. J Biol Chem 271:16439-16442.
26. Wolthuis RM, Franke B, van Triest M, Bauer B, Cool RH, CamonisJH et al. (1998). Activation of the small GTPase Ral in platelets.Mol Cell Biol 18: 2486-2491.
27. Wu JC, Chen TY, Yu CT, Tsai SJ, Hsu JM, Tang MJ et al. (2005).Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small poolexpression screening. J Biol Chem 280: 9013-9022.
28. Yin J, Pollock C, Tracy K, Chock M, Martin P, OberstMet al. (2007).Activation of the RalGEF/Ral pathway promotes prostate cancermetastasis to bone. Mol Cell Biol 27: 7538-7550.